Jang Won Son

2.4k total citations · 1 hit paper
53 papers, 940 citations indexed

About

Jang Won Son is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Jang Won Son has authored 53 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Physiology. Recurrent topics in Jang Won Son's work include Metabolism, Diabetes, and Cancer (12 papers), Diabetes Treatment and Management (11 papers) and Nutrition and Health in Aging (6 papers). Jang Won Son is often cited by papers focused on Metabolism, Diabetes, and Cancer (12 papers), Diabetes Treatment and Management (11 papers) and Nutrition and Health in Aging (6 papers). Jang Won Son collaborates with scholars based in South Korea, United States and United Kingdom. Jang Won Son's co-authors include Sungrae Kim, Soon Jib Yoo, Hwa–Young Son, Kyungdo Han, Seong Su Lee, Sung Rae Kim, Jin‐Hyung Jung, Bong Yun, Nam H. Cho and Byoungduck Han and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Endocrine Reviews.

In The Last Decade

Jang Won Son

45 papers receiving 922 citations

Hit Papers

Obesity Fact Sheet in Korea, 2021: Trends in Obesity Prev... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jang Won Son South Korea 17 320 270 199 131 126 53 940
Gwanpyo Koh South Korea 17 226 0.7× 348 1.3× 217 1.1× 87 0.7× 167 1.3× 57 939
Carlos Morillas Spain 23 337 1.1× 347 1.3× 299 1.5× 84 0.6× 260 2.1× 74 1.2k
Elizabeth J. Simpson United Kingdom 20 571 1.8× 165 0.6× 227 1.1× 83 0.6× 106 0.8× 58 1.3k
Takaya Nakane Japan 14 250 0.8× 163 0.6× 198 1.0× 132 1.0× 93 0.7× 46 831
Zilin Sun China 18 311 1.0× 306 1.1× 185 0.9× 59 0.5× 188 1.5× 58 895
Beata Telejko Poland 19 222 0.7× 239 0.9× 117 0.6× 119 0.9× 149 1.2× 59 1.2k
Jaimar C. Rincon Venezuela 17 155 0.5× 189 0.7× 168 0.8× 102 0.8× 87 0.7× 43 1.1k
Zohaib Iqbal United Kingdom 13 326 1.0× 183 0.7× 87 0.4× 80 0.6× 163 1.3× 29 858
Margarita Torres‐Tamayo Mexico 14 298 0.9× 233 0.9× 107 0.5× 182 1.4× 119 0.9× 50 969

Countries citing papers authored by Jang Won Son

Since Specialization
Citations

This map shows the geographic impact of Jang Won Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jang Won Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jang Won Son more than expected).

Fields of papers citing papers by Jang Won Son

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jang Won Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jang Won Son. The network helps show where Jang Won Son may publish in the future.

Co-authorship network of co-authors of Jang Won Son

This figure shows the co-authorship network connecting the top 25 collaborators of Jang Won Son. A scholar is included among the top collaborators of Jang Won Son based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jang Won Son. Jang Won Son is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Son, Jang Won, Carel W. le Roux, Matthias Blüher, Michael A. Nauck, & Soo Lim. (2025). Novel GLP-1-based Medications for Type 2 Diabetes and Obesity. Endocrine Reviews. 47(2). 159–177. 1 indexed citations
2.
Seo, Je Hyun, Bumjo Oh, Sungkyoung Choi, et al.. (2025). Association of Multiple-trait Polygenic Risk Score with Obesity and Cardiometabolic Diseases in Korean Population. Genomics Proteomics & Bioinformatics. 23(5).
3.
Lee, Joonyub, Seung‐Hwan Lee, Meekyoung Kim, et al.. (2025). Inverse association between obesity and suicidal death risk. BMC Psychiatry. 25(1). 27–27.
4.
Son, Jang Won, et al.. (2024). Development and clinical application of bioelectrical impedance analysis method for body composition assessment. Obesity Reviews. 26(1). e13844–e13844. 16 indexed citations
5.
Lee, Jaewoong, Jaeeun Yoo, Eun Sook Kim, et al.. (2024). Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review. Annals of Laboratory Medicine. 44(6). 591–597.
6.
Ryu, Seung Woo, Geu‐Ru Hong, Jung Sun Cho, et al.. (2024). High prevalence of ALPK3 premature terminating variants in Korean hypertrophic cardiomyopathy patients. Frontiers in Cardiovascular Medicine. 11.
7.
Kirtipal, Nikhil, et al.. (2024). Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response. Diabetes & Metabolism Journal. 48(5). 821–836. 3 indexed citations
8.
Son, Jang Won & Soo Lim. (2024). Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management. Endocrinology and Metabolism. 39(2). 206–221. 9 indexed citations
9.
Kim, Bo‐Yeon, Hye‐Mi Lee, So Hun Kim, et al.. (2023). Association of Blood Pressure With Cardio-Renal Events and Mortality in Type 2 DM: A National Health Insurance Database. The Journal of Clinical Endocrinology & Metabolism. 109(1). 227–236. 1 indexed citations
10.
Hong, Oak‐Kee, Eun Sook Kim, Jang Won Son, et al.. (2023). Alcohol‐induced increase in BMP levels promotes fatty liver disease in male prediabetic stage Otsuka Long‐Evans Tokushima Fatty rats. Journal of Cellular Biochemistry. 124(3). 459–472. 1 indexed citations
11.
Han, Kyung Ah, Yong Hyun Kim, Doo Man Kim, et al.. (2023). Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial. Diabetes & Metabolism Journal. 47(6). 796–807. 12 indexed citations
12.
Son, Jang Won, Sukho Lee, Minsoo Kang, Yun‐A Shin, & Jae‐Hyun Kim. (2022). Optimal Frequency Intensity of Physical Activity to Reduce the Risk of Hypertension in the Korean Population. SHILAP Revista de lepidopterología. 31(1). 129–140.
13.
Kim, Ji-Hoon, et al.. (2022). Human Tissue-Engineered Skeletal Muscle: A Tool for Metabolic Research. Endocrinology and Metabolism. 37(3). 408–414. 3 indexed citations
14.
Kim, Bo-Yeon, Seon Mee Kang, Jee‐Hyun Kang, et al.. (2020). Current Long-Term Pharmacotherapies for the Management of Obesity. Journal of Obesity & Metabolic Syndrome. 29(2). 99–109. 19 indexed citations
16.
Son, Jang Won, Seong Su Lee, Sung Rae Kim, et al.. (2017). Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 60(5). 865–872. 161 indexed citations
17.
Kim, Yang‐Hyun, Seon Mee Kim, Kyungdo Han, et al.. (2017). Change in Weight and Body Mass Index Associated With All-Cause Mortality in Korea: A Nationwide Longitudinal Study. The Journal of Clinical Endocrinology & Metabolism. 102(11). 4041–4050. 40 indexed citations
18.
Ahn, Jihyun, Hongryeol Park, Jang Won Son, et al.. (2012). Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation. Cardiovascular Research. 94(1). 105–114. 44 indexed citations
19.
Kim, Mee Kyoung, Eun‐Hee Jang, Jang Won Son, et al.. (2011). Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 93(2). 174–178. 10 indexed citations
20.
Kim, Min Young, Jang Won Son, & Myung‐Haing Cho. (2001). Genotoxicity in B6C3F1 Mice Following 0.5 ppm Ozone Inhalation. Toxicological Research. 17(1). 1–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026